Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
about
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation SequencingSimultaneous human platelet antigen genotyping and detection of novel single nucleotide polymorphisms by targeted next-generation sequencing.An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractorinessDeveloping Molecular Signatures for Chronic Lymphocytic Leukemia.Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutationsExtensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlationsA targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing.Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors.Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia.Development of locus specific sub-clone separation by fluorescence in situ hybridization in suspension in chronic lymphocytic leukemia.ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
P2860
Q27853333-320ABD3D-BC50-4FA6-8F3B-CE82A9F9B44CQ28547976-BD650C66-325D-429C-BA27-64E348E87F68Q33440638-F358BD8C-4F5F-4F00-8099-61E694DB5BBAQ33709543-A94837CE-7644-40AD-8C27-1DD98C31FDCEQ35653850-A8474A9F-1B3A-4AD2-AB96-2B013247DCEEQ36222022-22DC0FAC-D537-4D68-9D15-C4A8653EF5A7Q36622188-675B5949-4106-46D2-8A1D-F9BAAD79866BQ37260520-2E737148-FD23-4109-B4E0-B0C458EB7E96Q37648114-AD13F1DF-8B90-488A-8270-579D55989BC2Q38744632-DE924768-81E1-4BC2-AC1F-A90D48FCA058Q40455172-DFCE6CC5-3300-4565-A901-E6DAFDFCA7D8Q42367931-B4484E48-6E32-4ABB-8D2C-41E647E8E61CQ42378526-C7BD0BD8-F999-4EF5-BCB6-D0A6C2DBF194Q42923891-5AE82F21-7E85-4169-B7EF-C79C03C9D433Q47823277-ED985A36-75E6-4995-B919-97F4DCF5BDE6Q48138435-8E3DD56E-D852-4A02-995E-10E7F9CEB761Q48575290-B2140AEF-56E3-4296-965E-FBF006961084Q50146313-1846AA45-D8E0-4173-B5B5-BA23991A5B31
P2860
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeted next-generation seque ...... ntation in a clinical setting.
@ast
Targeted next-generation seque ...... ntation in a clinical setting.
@en
type
label
Targeted next-generation seque ...... ntation in a clinical setting.
@ast
Targeted next-generation seque ...... ntation in a clinical setting.
@en
prefLabel
Targeted next-generation seque ...... ntation in a clinical setting.
@ast
Targeted next-generation seque ...... ntation in a clinical setting.
@en
P2093
P2860
P50
P1433
P1476
Targeted next-generation seque ...... ntation in a clinical setting.
@en
P2093
Alice F Muggen
Anton W Langerak
Chrysoula Belessi
Diego Cortese
Emma Young
Frederic Davi
Jitka Malcikova
Kostas Stamatopoulos
Larry Mansouri
Lesley-Ann Sutton
P2860
P304
P356
10.3324/HAEMATOL.2014.109777
P577
2014-12-05T00:00:00Z